Novel nanoparticle SARS-CoV-2 vaccine combines immune focusing and self-assembling nanoparticles to elicit more potent protection: Engineered to use DNA to instruct cells to make vaccine in vivo, and can be stored at room temperature, easily transported to remote locations
| Date | 1st, Feb 2022 |
|---|---|
| Source | ScienceDaily - General News Websites |
DESCRIPTION
First generation COVID-19 vaccines have been highly effective, but also have limitations. Now, scientists have developed a more targeted vaccine that, in animal studies, shows stronger, broader, and more durable protection in a single, low dose.